Morningstar Investment Services LLC Sells 15,851 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Morningstar Investment Services LLC decreased its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV – Get Rating) by 2.3% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 665,556 shares of the medical research company’s stock after selling 15,851 shares during the period. IQVIA makes up approximately 1.9% of Morningstar Investment Services LLC’s investment portfolio, making the stock its 11th biggest position. Morningstar Investment Services LLC’s holdings in IQVIA were worth $137,747,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Glassy Mountain Advisors Inc. purchased a new stake in IQVIA during the fourth quarter valued at about $31,000. Spire Wealth Management increased its holdings in shares of IQVIA by 40.3% in the fourth quarter. Spire Wealth Management now owns 167 shares of the medical research company’s stock worth $34,000 after buying an additional 48 shares during the period. Hollencrest Capital Management purchased a new position in shares of IQVIA in the fourth quarter worth about $41,000. Heritage Wealth Advisors purchased a new position in shares of IQVIA in the fourth quarter worth about $43,000. Finally, Allworth Financial LP increased its holdings in shares of IQVIA by 36.4% in the fourth quarter. Allworth Financial LP now owns 221 shares of the medical research company’s stock worth $45,000 after buying an additional 59 shares during the period. Institutional investors own 86.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on IQV shares. Truist Financial cut their target price on IQVIA from $265.00 to $244.00 in a research note on Monday, May 1st. Guggenheim cut their target price on IQVIA from $266.00 to $258.00 in a research note on Friday, April 28th. Robert W. Baird cut their target price on IQVIA from $240.00 to $235.00 in a research note on Friday, April 28th. JPMorgan Chase & Co. lifted their price objective on IQVIA from $257.00 to $263.00 and gave the company an “overweight” rating in a research report on Monday, February 27th. Finally, Credit Suisse Group reiterated an “outperform” rating and set a $265.00 target price on shares of IQVIA in a report on Monday, February 13th. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, IQVIA currently has a consensus rating of “Moderate Buy” and a consensus target price of $253.25.

IQVIA Stock Up 0.9 %

IQV stock traded up $1.85 during midday trading on Friday, hitting $199.32. The company’s stock had a trading volume of 243,910 shares, compared to its average volume of 1,061,282. The company has a market cap of $36.98 billion, a PE ratio of 35.52, a P/E/G ratio of 1.99 and a beta of 1.39. IQVIA Holdings Inc. has a 12 month low of $165.75 and a 12 month high of $249.11. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 1.99. The firm’s 50-day moving average is $194.16 and its 200-day moving average is $208.10.

IQVIA Profile

(Get Rating)

IQVIA Holdings, Inc engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm’s life science clients.